Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Nature|January 21, 1993
Human TNF mutants with selective activity on the p55 receptorX Van Ostade, P Vandenabeele, B Everaerdt, et al.
Journal of Molecular Biology|January 20, 1993
Crystallization and preliminary crystallographic analysis of a TNF-beta-55 kDa TNF receptor complexA D'Arcy, D W Banner, W Janes, et al.
The Journal of Biological Chemistry|September 25, 1991
Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activityH Loetscher, R Gentz, M Zulauf, et al.
The Journal of Clinical Investigation|July 1, 1994
Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptorsL S Rusten, E B Smeland, F W Jacobsen, et al.
European Journal of Immunology|November 1, 1991
Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethalityW Lesslauer, H Tabuchi, R Gentz, et al.
Cell|December 1, 1995
The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptorM Grell, E Douni, H Wajant, et al.
The Journal of Infectious Diseases|July 1, 1997
Pretreatment with a 55-kDa tumor necrosis factor receptor-immunoglobulin fusion protein attenuates activation of coagulation, but not of fibrinolysis, during lethal bacteremia in baboonsT van der Poll, P M Jansen, K J Van Zee, et al.
JAMA|May 21, 1997
p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study GroupE Abraham, M P Glauser, T Butler, et al.
Blood|August 1, 1996
Tumor necrosis factor-alpha induces activation of coagulation and fibrinolysis in baboons through an exclusive effect on the p55 receptorT van der Poll, P M Jansen, K J Van Zee, et al.
Critical Care Medicine|May 25, 2001
Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patientsE Abraham, P F Laterre, J Garbino, et al.
Pageof 7